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analysis of prognostic factors was performed using the Cox 
proportional hazards model and logistic regression analysis. 
 
Results: 155 eligible patients had their data analyzed for this 
work. The median age was 58.7 years (range 31-86). 55 
patients suffered from coexisting comorbidities. All patients 
underwent surgery; a total abdominal hysterectomy plus 
bilateral salpingo-oopherectomy in 92.2%. Lymphadenectomy 
was realized in only 23 patients.They were classified 
according to FIGO stage on (91 I, 24 II, 29 III, 10 IVA). 
Myometrial invasion was > 50 % in 80%. Type1 endometrial 
carcinoma represents the most common type (134 patients). 
Histologic low-grade (G1–2) was found in 77.4%. 154 patients 
received radiotherapy; in 79 cases external beam Radiation 
therapy (EBRT) was associated with vaginal brachytherapy 
(VB). After median follow up of 72 months (2 -144 months) 
loco-regional recurrence occurred in 10 patients (5.1%) and 
metastasis in12 patients (7.7%), the 5-year overall survival 
(OS) and the Disease Free Survival (DFS) was 88,4%, and 
76,1% respectively. DFS was highly significant for: histologic 
type 1vs 2 (p=0.005), histology grade 1-2 vs 3 (p= 0.03) and 
stage I-II vs III-IV (p= 0.04), The addition of VB to EBRT 
revealed statistically significant effect on DFS (p= 0.02).  
 
Conclusion: In our study, tumor’s histology type, grad, and 
FIGO stage are the important prognostic factors and should 
be considered when making treatment decisions. Delivery of 
adjuvant EBRT+VB seems to be a significant independent 
predictor for improved survival and pelvic control. Further 
studies on larger cohorts are necessary for the validation of 
those results. 
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Purpose or Objective: The present study was done to 
evaluate the impact of lymph node on survival outcome of 
cancer cervix treated by chemo-radiotherapy in a tertiary 
care hospital in a northern part of India 
 
Material and Methods: Between Jan 2008- Dec 2011, 300 
cervical cancer patients were registered. Medical records 
were retrieved and documented for various host and 
treatment related parameters and outcomes. Local disease 
free survival (LDFS) and overall survival (OS) was calculated 
from time of registration and computed by Kaplan–Meier 
method. Death due to any cause or loss to follow-up was 
considered as an event for survival analysis i.e. assuming the 
worst case scenario. 
 
Results: Of 300 patients, 72 (24%) did not report after first 
consultation while 64 (21%) were referred for brachytherapy 
from outside medical facilities. For present analysis, 164 
(55%) patients who received treatment with either radical or 
palliative intent in our department were studied. Of 164 
cases, 76%, 15% and 9% presented as de novo cervical cancer, 
post-operative and stump carcinoma respectively. The 
median age (range) at presentation was 52years (26–90), 75% 
were postmenopausal. MRI was preferred pre staging imaging 
modality in half followed by ultrasound .FIGO stage I–IV was 
17%, 37%, 30% and 16% respectively with more than half 
having bulky disease and a third presenting with regional 
lymph nodes and 10% had para-aortic lymph nodes seen on 
imaging at presentation. 93% patients were treated with 
radical while 7% with palliative intent. Two thirds received 
concurrent platin based chemoradiotherapy. Brachytherapy 
was taken by 80% cases. Patients were kept on clinical follow 
up and imaging was done as and when required.  
At the time of analysis 38% are disease free and alive, 21 % 
dead while 40 % were lost to follow-up with or without 
disease. At median follow up of 24 months (0-90), LDFS for 
stage I, II, III and IV was NR (not reached), NR, 17 and 0 
months, p=0.000 while median OS was NR, NR, 17 and 8, 
p=0.000 respectively. The median OS stage-wise with or 
without lymph node presence was - Stage I 27m vs. NR; Stage 
II 46m vs.NR; Stage III 14m vs. 17m and Stage IV 9m vs 2m; 
p=0.000 respectively. Those receiving chemotherapy in 
presence of lymph nodes had a better survival outcome 
median 21m vs 5m p=0.001. 
 
Conclusion: Cervical cancer presented in bulky advanced 
stages with regional and metastatic spread at time of 
presentation. The presence of lymph node decreased survival 
in all stages. The addition of chemotherapy improved survival 
outcome. 
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Purpose or Objective: Synchronous primary endometrial and 
ovarian cancers are infrequent. The objective of this study is 
to evaluate clinicopathological characteristics and treatment 
outcomes of synchronous endometrial and ovarian cancer 
treated in our institution. 
 
Material and Methods: The clinicopathological 
characteristics of 12 patients with synchronous ovarian and 
endometrial cancer treated at SKMCH from July 2005 to July 
2015 were reviewed retrospectively. Their medical records 
and pathology reports were reviewed in depth from hospital 
database. The histologic determination was followed by the 
World Health Organization Committee classification, and 
cancer stage was based on FIGO. 
 
Results: The median age at the time of diagnosis was 50 
years (Range23-66).The incidence of synchronous primary 
endometrial and ovarian cancers was 2.01 % in patients with 
endometrial cancer. A total of 7 patients were menopausal 
(58%), 8 patients were nulliparous (66%) the median BMI was 
29 kg/m2 (range, 20–38). The most common presenting 
symptom was abnormal uterine bleeding. According to FIGO 
stage 10 cases of endometrial were I /II (88%) and 2 cases 
were stage III (16%). Of the ovarian cancers, 9 cases were 
stage I/II 83.3% and 2 cases were stage III (16.7%). 
Endometroid cancer was the main pathological type in 
uterine carcinoma (86%) followed by serous carcinoma (14%) 
and similarly for ovarian cancer endometroid was the most 
common pathology 67 % followed by serous/clear cell 16% 
and mucinous 16.7%. Most endometrial and ovarian primaries 
in our series were grade I and II tumors, 83% and 66% 
respectively. 
8 patients (66%) had similar histology in both primaries while 
4 patients (44%) had different histology. All patients 
underwent surgical intervention. Only one patient did not 
receive any postoperative adjuvant therapy. 10 patients 
received platinum-based adjuvant chemotherapy and six 
patients received adjuvant radiotherapy 
 
Conclusion: Synchronous primary endometrial and ovarian 
cancers are infrequent and distinct set of patients. Abnormal 
PV bleed was the most common symptom which helped in 
early detection. Majority of the patients belong to 
concordant endometroid histology, low grade, had younger 
age and High BMI. Treatment should be tailored to the stage, 
histology, and grade of the individual tumors. 
 
 
 
 
